Trenbolone acetate (TBA), an implant (Finaplix®) with androgenic activity, stimulates growth and enhances feed efficiency much like implants with estrogenic activity (Ralgro®, Synovex®, Implus® and Compudose®). Because androgenic and estrogenic products tend to have different mechanisms of action, the combination of TBA and an estrogenic implant have been shown to be most beneficial. Revalor® S, a combination product containing 24 mg estradiol (E2) and 120 mg TBA. is an effective implant. particularly when used in feedlot steers 100 to 120 days before slaughter. Other products and combinations of TBA and estradiol may be just as effective. The objective of this study was to evaluate Synovex® Plus, a new combination implant currently being c...
Two hundred-sixteen Angus and Angus-cross steer calves (690 lb) were used in a 129- day finishing st...
Angus and Angus-cross calves (632 lb) were utilized in a finishing study to evaluate the effects o...
Objective: Evaluate the effects of increasing doses of trenbolone acetate and estradiol as terminal...
Trenbolone acetate (TBA), an implant (Finaplix®) with androgenic activity, stimulates growth and enh...
The use of growth promoting implants with finishing cattle is common feedlot practice to increase we...
In a commercial feedyard trial, 242 Holstein steer calves averaging 378 lb were used to compare ef...
In a commercial feedyard trial, 242 Holstein steer calves averaging 378 lb were used to compare ef...
In a commercial feedyard trial, 242 Holstein steer calves averaging 378 lb were used to compare effe...
The use of growth promoting implants with finishing cattle is common feedlot practice to increase we...
Two hundred-sixteen Angus and Angus-cross steer calves (690 lb) were used in a 129- day finishing ...
Two hundred-sixteen Angus and Angus-cross steer calves (690 lb) were used in a 129- day finishing ...
Angus and Angus-cross calves (632 lb) were utilized in a finishing study to evaluate the effects o...
Yearling steers (n = 400) were used to evaluate relative payout periods for implants when feeding hi...
Angus and Angus-cross calves (632 lb) were utilized in a finishing study to evaluate the effects of ...
Yearling steers (n = 400) were used to evaluate relative payout periods for implants when feeding hi...
Two hundred-sixteen Angus and Angus-cross steer calves (690 lb) were used in a 129- day finishing st...
Angus and Angus-cross calves (632 lb) were utilized in a finishing study to evaluate the effects o...
Objective: Evaluate the effects of increasing doses of trenbolone acetate and estradiol as terminal...
Trenbolone acetate (TBA), an implant (Finaplix®) with androgenic activity, stimulates growth and enh...
The use of growth promoting implants with finishing cattle is common feedlot practice to increase we...
In a commercial feedyard trial, 242 Holstein steer calves averaging 378 lb were used to compare ef...
In a commercial feedyard trial, 242 Holstein steer calves averaging 378 lb were used to compare ef...
In a commercial feedyard trial, 242 Holstein steer calves averaging 378 lb were used to compare effe...
The use of growth promoting implants with finishing cattle is common feedlot practice to increase we...
Two hundred-sixteen Angus and Angus-cross steer calves (690 lb) were used in a 129- day finishing ...
Two hundred-sixteen Angus and Angus-cross steer calves (690 lb) were used in a 129- day finishing ...
Angus and Angus-cross calves (632 lb) were utilized in a finishing study to evaluate the effects o...
Yearling steers (n = 400) were used to evaluate relative payout periods for implants when feeding hi...
Angus and Angus-cross calves (632 lb) were utilized in a finishing study to evaluate the effects of ...
Yearling steers (n = 400) were used to evaluate relative payout periods for implants when feeding hi...
Two hundred-sixteen Angus and Angus-cross steer calves (690 lb) were used in a 129- day finishing st...
Angus and Angus-cross calves (632 lb) were utilized in a finishing study to evaluate the effects o...
Objective: Evaluate the effects of increasing doses of trenbolone acetate and estradiol as terminal...